These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8301670

  • 1. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats.
    Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T.
    J Mol Cell Cardiol; 1993 Nov; 25(11):1369-80. PubMed ID: 8301670
    [Abstract] [Full Text] [Related]

  • 2. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
    Nishikimi T, Yamagishi H, Takeuchi K, Takeda T.
    Cardiovasc Res; 1995 Jun; 29(6):856-61. PubMed ID: 7656290
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
    Nishikimi T, Tani T, Ohmura T, Yamagishi H, Yanagi S, Yoshiyama M, Toda I, Teragaki M, Akioka K, Takeuchi K.
    Jpn Circ J; 1995 Nov; 59(11):754-61. PubMed ID: 8747765
    [Abstract] [Full Text] [Related]

  • 4. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
    Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M.
    J Clin Invest; 1995 Jan; 95(1):46-54. PubMed ID: 7814645
    [Abstract] [Full Text] [Related]

  • 5. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG, Scheer C, Rupp H.
    J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
    [Abstract] [Full Text] [Related]

  • 6. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats.
    Makino N, Hata T, Sugano M, Dixon IM, Yanaga T.
    J Mol Cell Cardiol; 1996 Mar; 28(3):507-17. PubMed ID: 9011634
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats.
    Yoshiyama M, Omura T, Takeuchi K, Kim S, Shimada K, Yamagishi H, Teragaki M, Akioka K, Iwao H, Yoshikawa J.
    J Mol Cell Cardiol; 2001 Apr; 33(4):799-810. PubMed ID: 11273732
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
    El-Sabban ME, Hassan KA, Birbari AE, Bitar KM, Bikhazi AB.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):369-78. PubMed ID: 11967826
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.
    Omura T, Kim S, Takeuchi K, Iwao H, Takeda T.
    Cardiovasc Res; 1994 Dec; 28(12):1835-42. PubMed ID: 7867037
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction.
    Omura T, Yoshiyama M, Takeuchi K, Kim S, Iwao H, Yamagishi H, Toda I, Teragaki M, Akioka K, Yoshikawa J.
    J Mol Cell Cardiol; 2000 Jan; 32(1):23-33. PubMed ID: 10652187
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
    Hanatani A, Yoshiyama M, Takeuchi K, Kim S, Nakayama K, Omura T, Iwao H, Yoshikawa J.
    Jpn J Pharmacol; 1998 Sep; 78(1):45-54. PubMed ID: 9804061
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II receptor binding following myocardial infarction in the rat.
    Sun Y, Weber KT.
    Cardiovasc Res; 1994 Nov; 28(11):1623-8. PubMed ID: 7842454
    [Abstract] [Full Text] [Related]

  • 14. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K, Kobayashi N, Watanabe S, Tsubokou Y, Matsuoka H.
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 16. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Katoh K, Fukuchi S.
    Life Sci; 1994 Nov; 54(25):1987-94. PubMed ID: 8201847
    [Abstract] [Full Text] [Related]

  • 17. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW, Huang YW, Xia Q, Xu QW.
    Chin Med J (Engl); 2005 Jan 20; 118(2):146-54. PubMed ID: 15667801
    [Abstract] [Full Text] [Related]

  • 18. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
    Lax CJ, Domenighetti AA, Pavia JM, Di Nicolantonio R, Curl CL, Morris MJ, Delbridge LM.
    Clin Exp Pharmacol Physiol; 2004 Aug 20; 31(8):512-7. PubMed ID: 15298543
    [Abstract] [Full Text] [Related]

  • 19. Regional changes in angiotensin II receptor density after experimental myocardial infarction.
    Lefroy DC, Wharton J, Crake T, Knock GA, Rutherford RA, Suzuki T, Morgan K, Polak JM, Poole-Wilson PA.
    J Mol Cell Cardiol; 1996 Feb 20; 28(2):429-40. PubMed ID: 8729073
    [Abstract] [Full Text] [Related]

  • 20. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1 H-benzimidazole-7-carboxylate. Part II: Effect on cardiovascular system and renal functions.
    Kito G, Ito K, Shiomi M.
    Arzneimittelforschung; 1996 Jul 20; 46(7):681-6. PubMed ID: 8842337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.